Table 2. Drugs assumed by the 1185 patients, classified according to the WHO ATC system.
| ATC code | Description | Category | No. of pts. | (%) |
|---|---|---|---|---|
| A | Alimentary tract and metabolism | 542 | (45.7) | |
| A01 | Stomatologicals | SE | 9 | (0.8) |
| A02 | Antacids and drugs for treatment of peptic ulcer | SE | 245 | (20.7) |
| A03 | Antispasmodic, anticholinergics and propulsives | SE | 148 | (12.5) |
| A04 | Antiemetics and antinauseants | SE | 193 | (16.3) |
| A06 | Laxatives | SE | 116 | (9.8) |
| A07 | Antidiarrhoeals and intestinal anti-infective agents | SE | 31 | (2.6) |
| A10 | Drugs used in diabetes | CD | 18 | (1.5) |
| A11 | Vitamins | – | 71 | (6) |
| A12 | Mineral supplements | – | 4 | (0.3) |
| A14 | Anabolic agents for systemic use | TS | 12 | (1) |
| A15 | Appetite stimulants | TS | 1 | (0.1) |
| B | Blood and blood-forming organs | 150 | (12.7) | |
| B01 | Antithrombotic agents | TS | 35 | (3) |
| B02 | Antihaemorrhagics | SE | 43 | (3.6) |
| B03 | Antianaemic preparations | SE | 54 | (4.6) |
| C | Cardiovascular system | CD | 141 | (11.9) |
| D | Dermatologicals | CD | 3 | (0.3) |
| G | Genitourinary system and sex hormones | 4 | (0.3) | |
| G04 | Drugs for benign prostatic hypertrophy | CD | 4 | (0.3) |
| H | Systemic hormonal preparations | 420 | (35.4) | |
| H01AA | ACTH | TS | 39 | (3.3) |
| H02 | Corticosteroids for systemic use | TS | 396 | (33.4) |
| H03 | Thyroid therapy | CD | 3 | (0.2) |
| J | General anti-infectives for systemic use | 126 | (10.6) | |
| J01 | Antibacterials for systemic use | SE | 114 | (9.6) |
| J02 | Antimycotics for systemic use | SE | 20 | (1.7) |
| L | Antineoplastic and immunomodulating agents | 113 | (9.5) | |
| L02AB | Progestogens | TS | 18 | (1.5) |
| L03AA | Colony-stimulating factors | SE | 97 | (8.2) |
| M | Muscoloskeletal agents | 222 | (18.7) | |
| M01A | Nonsteroidal anti-inflammatory drugs | TS | 200 | (16.9) |
| M05B | Drugs affecting mineralisation | TS | 34 | (2.9) |
| N | Nervous system (inch. Analgesics) | 282 | (23.8) | |
| N02A | Opioids | TS | 117 | (9.9) |
| N02B | Other analgesics and antipyretics | TS | 143 | (12.1) |
| N03 | Antiepileptics | TS | 6 | (0.5) |
| N05 | Psycoleptics | CD | 36 | (3) |
| N06 | Psycoanaleptics | CD | 15 | (1.3) |
| N07C | Antivertigo preparations | CD | 2 | (0.2) |
| P | Antiparasitic products | CD | 0 | – |
| R | Respiratory system | 195 | (16.5) | |
| R03 | Antiasthmatics | TS | 95 | (8) |
| R05C | Expettorants | TS | 47 | (4) |
| R05D | Cough suppressants | TS | 90 | (7.6) |
| S | Sensory organs | CD | 3 | (0.3) |
| V | Various | – | 23 | (1.9) |
SE=against side effects of treatment; TS=against tumour symptoms; CD=against concomitant diseases.